http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7033026-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02735aa33a78b800659e6e8ddaa6f2d1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4041
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-0484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-00
filingDate 2003-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b052bb9e3850aa3e468ee99d9364c454
publicationDate 2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7033026-B2
titleOfInvention Method of and apparatus for diagnosing and treating amblyopic conditions in the human visual system
abstract A method of and apparatus for diagnosing and treating amblyoptic conditions within the human vision system, wherein optical magnification is used to provide an amblyopic eye with more photonic energy than the non-amblyopic eye during treatment so as to over-stimulate the neural pathways along the visual channel of the amblyopic eye, and eventually achieve harmony along the both visual channels of the patient over the course of treatment, without the use of occlusion therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011013138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9597253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8002409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11452441-B2
priorityDate 2003-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003214630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6540900-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6273092-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003208265-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129143706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642

Total number of triples: 31.